Microport Scientific (853.HK) Stock Price
Microport Scientific Price
Revenue has compounded at 18.8% per year over the past 17 years to 1.03 B USD. Earnings per share have grown at 7.3% per year over the last 12 years. Microport Scientific's net margin stands at -20.8%, up from -29.5% several years earlier. Of 10 analysts, 7 rate the stock a buy — an overall Buy consensus.
Microport Scientific stock price
Details
Stock Price
ⓘHow to Read This Chart
This chart tracks the historical stock price of Microport Scientific over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.
Total Return vs. Price Return
The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.
Intraday Price Data
When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Microport Scientific stock reacts to market openings, earnings releases, or breaking news throughout the trading session.
What to Look For
Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Microport Scientific's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.
| Date | Microport Scientific Price |
|---|
Microport Scientific Revenue, EBIT, Net Income
3 Years
5 Years
10 Years
25 Years
Max
Details
Microport Scientific Income Statement, Balance Sheet, Cash Flow Statement
| REVENUEB USD |
|---|
| REVENUE GROWTH% |
| GROSS MARGIN% |
| GROSS INCOMEB USD |
| EBITM USD |
| EBIT MARGIN% |
| NET INCOMEM USD |
| NET INCOME GROWTH% |
| DIVIDENDDIV.USD |
| DIVIDEND GROWTHDIV. GROWTH% |
| SHARESB |
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025e | 2026e | 2027e | 2028e | 2029e | 2030e | 2031e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.39 | 0.44 | 0.67 | 0.79 | 0.65 | 0.78 | 0.84 | 0.95 | 1.03 | 1.14 | 1.29 | 1.48 | 1.68 | 1.90 | 2.13 | 2.33 |
| 3.73 | 14.14 | 50.68 | 18.54 | -18.28 | 20.06 | 7.97 | 13.10 | 8.53 | 10.18 | 13.56 | 14.57 | 13.40 | 13.07 | 12.56 | 9.00 |
| 69.67 | 71.62 | 70.25 | 71.12 | 67.28 | 63.11 | 59.64 | 56.00 | 55.67 | 55.67 | 55.67 | 55.67 | 55.67 | 55.67 | 55.67 | 55.67 |
| 0.27 | 0.32 | 0.47 | 0.56 | 0.44 | 0.49 | 0.50 | 0.53 | 0.57 | 0.63 | 0.72 | 0.82 | 0.93 | 1.06 | 1.19 | 1.29 |
| 38.00 | 62.00 | 48.00 | 26.00 | -162.00 | -339.00 | -506.00 | -374.00 | -117.00 | -9.00 | 111.00 | 189.00 | 456.00 | 574.00 | – | – |
| 9.77 | 13.96 | 7.17 | 3.28 | -25.00 | -43.57 | -60.24 | -39.37 | -11.35 | -0.79 | 8.60 | 12.79 | 27.21 | 30.29 | – | – |
| 14.00 | 18.00 | 23.00 | 46.00 | -191.00 | -276.00 | -436.00 | -477.00 | -214.00 | -57.00 | 57.00 | 101.00 | – | – | – | – |
| -216.67 | 28.57 | 27.78 | 100.00 | -515.22 | 44.50 | 57.97 | 9.40 | -55.14 | -73.36 | -200.00 | 77.19 | – | – | – | – |
| – | 0.02 | 0.03 | 0.03 | 0.05 | 0.04 | – | – | – | 0.05 | 0.06 | 0.07 | – | – | – | – |
| – | – | 50.00 | – | 66.67 | -20.00 | – | – | – | – | 20.00 | 16.67 | – | – | – | – |
| 1.44 | 1.47 | 1.56 | 1.67 | 1.74 | 1.81 | 1.81 | 1.82 | 1.83 | 1.83 | 1.83 | 1.83 | 1.83 | 1.83 | 1.83 | 1.83 |
Details
Income Statement Key Figures
ⓘRevenue and Revenue Growth
Revenue is the starting point of every income statement — it measures the total sales Microport Scientific generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.
Gross Margin
Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Microport Scientific retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Microport Scientific's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.
EBIT and EBIT Margin
EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.
Net Income and Earnings Per Share (EPS)
Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.
Shares Outstanding
The total number of shares Microport Scientific has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.
Analyst Estimates
The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Microport Scientific's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.
Microport Scientific stock margins
3 Years
5 Years
10 Years
25 Years
Max
Details
Microport Scientific Stock Revenue, EBIT, Earnings per Share
3 Years
5 Years
10 Years
25 Years
Max
Details
Microport Scientific business model & stock analysis
Microport Scientific SWOT Analysis
Strengths
Microport Scientific Corp possesses several key strengths that contribute to its success:
- Strong research and development capabilities
- Diverse product portfolio covering various medical specialties
- Established presence in both domestic and international markets
- Robust financial performance and stable revenue growth
- Strong brand reputation and customer loyalty
Weaknesses
Despite its strengths, Microport Scientific Corp also faces certain weaknesses:
- Increased competition in the medical device industry
- Relatively high dependency on a few key markets
- Limited market share compared to some global competitors
- Susceptibility to regulatory changes and compliance requirements
- Occasional product quality issues and recalls
Opportunities
Microport Scientific Corp can capitalize on the following opportunities:
- Growing demand for minimally invasive medical devices
- Expanding healthcare infrastructure in emerging markets
- Strategic alliances and partnerships for new product development
- Increase market share through acquisitions
- Technological advancements driving innovation in medical devices
Threats
There are several potential threats that Microport Scientific Corp should consider:
- Stringent regulatory environment and approval processes
- Economic downturn impacting healthcare spending
- Intense competition from established and emerging players
- Intellectual property infringement and patent litigation
- Geopolitical and trade uncertainties affecting global markets
Microport Scientific Eulerpool Fair Value
Details
Fair Value Estimate
ⓘWhat Is Fair Value?
Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.
Earnings-Based Fair Value
Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.
Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021
Revenue-Based Fair Value
Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"
Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021
Dividend-Based Fair Value
Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.
Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021
How to Use This Chart
When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.
Microport Scientific historical P/E ratio, EBIT multiple, and P/S ratio
Microport Scientific annual returns
Details
Annual Return
ⓘWhat This Chart Shows
This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.
Price Return
Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.
Dividend Return
Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.
What to Look For
Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.
Microport Scientific shares outstanding
3 Years
5 Years
10 Years
25 Years
Max
Details
Microport Scientific Dividend History
8 years of dividend payments
Microport Scientific dividend history and estimates
Max
Details
Microport Scientific dividend payout ratio
3 Years
5 Years
10 Years
25 Years
Max
Details
Current Microport Scientific forecasts and price targets in August 2026
Analyst Price Targets 2026Microport Scientific Earnings Estimates & Surprises
| Date | EPS estimate | EPS Actual | Revenue Estimate | Price reaction | Quarterly report |
|---|---|---|---|---|---|
| 3/19/2012 | 0.01USD | - | 66.35 MUSD | - | 2011 Q4 |
| 8/26/2011 | 0.02USD | - | 69.06 MUSD | - | 2011 Q2 |
| 3/23/2011 | 0.01USD | - | 53.42 MUSD | - | 2010 Q4 |
EESG©
Eulerpool ESG Scorecard© for the Microport Scientific stock
EEnvironment
20
Environment
SSocial
20
Social
GGovernance (Corporate Governance)
4
Governance (Corporate Governance)
The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.
Microport Scientific shareholder structure
| % | Name |
|---|---|
26.06977% | |
7.38813% | |
6.26425% | |
5.04008% | |
1.63615% | |
0.71587% |
Microport Scientific Executives and Management Board
25 members · avg. age 53 · 16 % women
Dr. Zhaohua Chang (62)
Executive Chairman of the Board, Chief Executive Officer · since 2006
5.13 M USD
Management
Mr. Hongbin Sun (49)
Chief Financial Officer, Co-Chairperson of CEC and Member of ICC · since 2010
Mr. Jonathan Chen (50)
Rotating Co-Chief Executive Officer
Mr. Badhri Iyengar
President of MicroPort Orthopedics and Member of IOC
Mr. Jiang Lei
Chairman of the Board of Directors of Shanghai MicroPort Medical (Group), Co-Chairperson and Chief Marketing Officer of CEC, Chief Executive Officer of MicroPort Scientific (Shanghai) Co.
Dr. Philippe Wanstok
President of MicroPort CRM and Co-Chairperson of ICC · since 2024
Mr. Tianbai Yu
President of MicroPort Orthopedics China, Member of IOC and Member of the Board of Directors of Suzhou MicroPort Orthopedics Scientific (Group) Co., Ltd · since 2024
Board of Directors
Mr. Jonathan Chou (61)
Independent Non-Executive Director
Dr. Guoen Liu (68)
Independent Non-Executive Director
Mr. Chunyang Shao (61)
Independent Non-Executive Director
Dr. Feng Gu (53)
Non-Executive Director
Dr. Qingbing Men (48)
Non-Executive Director
Ms. Weiqin Sun (45)
Non-Executive Director
Frequently asked questions about Microport Scientific
The business model of Microport Scientific Corp. is centered around the research, development, and sale of high-quality medical devices. With a focus on improving healthcare outcomes, the company specializes in products for cardiovascular, orthopedic, and other medical specialties. Microport Scientific Corp. operates both domestically and internationally, catering to the needs of medical professionals and patients worldwide. By leveraging advanced technologies and innovative solutions, Microport aims to provide superior medical devices and therapies that enhance patient well-being. The company's commitment to excellence and continuous improvement has made it a prominent player in the global medical device industry.
Microport Scientific Corp is primarily active in the medical device industry.
The main competitors of Microport Scientific Corp in the market include companies such as Medtronic, Abbott Laboratories, Boston Scientific Corporation, and Johnson & Johnson. These companies operate in the medical device industry and offer similar products and solutions. Microport Scientific Corp competes with them in areas such as cardiac rhythm management, orthopedics, neurovascular, and endovascular businesses. These competitors play a significant role in shaping the competitive landscape for Microport Scientific Corp and drive innovation and advancements in the industry.
Microport Scientific Corp is a renowned medical device manufacturer based in Shanghai, China. Founded in 1998, the company has grown to become a leading player in the global cardiovascular industry. Microport specializes in the development, production, and distribution of innovative medical devices, including stents, artificial joints, electrophysiology devices, and more. With a strong emphasis on research and development, Microport strives to improve patient outcomes and enhance healthcare practices worldwide. Today, Microport Scientific Corp stands as a trusted brand in the medical field, committed to advancing medical technology and delivering high-quality products to healthcare providers and patients globally.
Some significant milestones that Microport Scientific Corp has achieved include successfully developing innovative medical technologies and gaining regulatory approvals for their products. The company has achieved milestones in the field of interventional cardiology and orthopedics, providing solutions for the treatment of cardiovascular diseases and joint disorders. Microport has also established strategic collaborations and expanded its global presence through acquisitions and partnerships. These accomplishments have strengthened Microport's position in the medical device industry and allowed them to continue delivering advanced healthcare solutions to patients worldwide.
Microport Scientific Corp is primarily present in several countries and regions, including the United States, China, Europe, and Asia-Pacific. With a global reach, Microport Scientific Corp has established its presence in key markets around the world. This enables the company to effectively serve its customers and expand its business operations.
Microport Scientific Corp is committed to delivering value-driven solutions and has a robust corporate philosophy. The company prioritizes innovation, aiming to provide cutting-edge medical devices and technology that enhance patient care. Microport focuses on creating medical solutions that are safe, effective, and accessible to a wide range of patients worldwide. Their commitment to quality and excellence is demonstrated through their stringent quality control processes and continuous improvement initiatives. With a customer-centric approach, Microport aims to meet the evolving needs of healthcare professionals and improve global healthcare outcomes. As a recognized industry leader, Microport Scientific Corp continues to drive advancements and make a positive impact in the medical field.
10 analysts currently rate the Microport Scientific stock: 7 recommend buying, 3 holding and 0 selling. For 2026, analysts expect Microport Scientific to generate revenue of 1.29 B USD and earnings per share of 0.03 USD.
The Microport Scientific share (853.HK) is listed on 3 stock exchanges, including: Frankfurt (MSK.F).
Microport Scientific Corp is a leading medical technology company based in Shanghai, China. The company focuses on the development and manufacturing of medical devices and implantable medical aids. The core business of Microport Scientific Corp currently includes three major divisions: cardiology, orthopedics, and endovascular therapy. These divisions are specifically designed to offer products and services to hospitals and clinics worldwide that help patients and support medical personnel in diagnosis and treatment. In the cardiology division, Microport Scientific Corp offers a wide range of products, including coronary stents, balloon dilators, heart valves, and electrophysiology products. These products assist in the treatment of cardiovascular diseases such as heart attack, angina, or arrhythmia. In the orthopedics field, the company focuses on the production of hip, knee, and shoulder endoprostheses, as well as trauma implants. These implants provide a solution for patients suffering from joint diseases or injuries. Additionally, Microport Scientific Corp also manufactures spinal implants that can assist in the treatment of back pain. The company's third division, endovascular therapy, focuses on the production of devices used in blood vessels. These products can be used in the treatment of aortic aneurysms and peripheral arterial diseases. In addition to these three main divisions, Microport Scientific Corp also produces products for other medical areas, such as pressure measurement and pulmonology. The business model of Microport Scientific Corp is to develop, manufacture, and distribute medical devices and implantable medical aids worldwide. The focus is on solving medical problems that are difficult or impossible for patients to solve. The company works closely with medical professionals to ensure that the products and services provided truly meet the needs of patients and medical personnel. Continuous investment in research and development is made to develop more innovative and effective medical devices. Furthermore, the company collaborates closely with hospitals and clinics to ensure that they receive the necessary products and services and that optimal patient care is provided. Overall, Microport Scientific Corp is a successful medical technology company that specializes in the development and manufacturing of medical devices and implantable medical aids. Through close collaboration with medical professionals and hospitals, the company is able to offer products and services that meet the needs of patients and also support medical personnel in diagnosis and treatment.
The expected revenue of Microport Scientific is 1.29 B USD. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Microport Scientific is 57.67 M USD. The net profit reflects the company's profitability after deducting all expenses.
The P/E ratio cannot be calculated for Microport Scientific at the moment.
The P/S cannot be calculated for Microport Scientific currently.
The Eulerpool Quality Score for Microport Scientific is 3/10.
The ISIN of Microport Scientific is KYG608371046. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of Microport Scientific is A1C5AB. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of Microport Scientific is 853.HK. The ticker symbol is used to trade Microport Scientific shares on the stock exchange.
The current dividend yield of Microport Scientific is - %.
Microport Scientific is assigned to the 'Health' sector.
The dividends of Microport Scientific are distributed in USD.
Microport Scientific stock
Microport Scientific Peer Group
Microport Scientific Ticker
Microport Scientific FIGI
All fundamentals and in-depth analysis of Microport Scientific
Our stock analysis for Microport Scientific stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Microport Scientific. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.